loading page

Transcriptomic profile of the maternal-fetal interface may reveal potential protective effects against miscarriage after COVID-19 vaccination
  • +7
  • yiyuan qu,
  • chengcheng zhu,
  • tao sun,
  • jianqiu jiang,
  • ying gu,
  • linping jin,
  • xujia huang,
  • bingbing wu,
  • jian xu,
  • xiuying chen
yiyuan qu
Zhejiang University
Author Profile
chengcheng zhu
Zhejiang University
Author Profile
tao sun
Zhejiang University
Author Profile
jianqiu jiang
Zhejiang University
Author Profile
ying gu
Zhejiang University
Author Profile
linping jin
Zhejiang University
Author Profile
xujia huang
Zhejiang University
Author Profile
bingbing wu
Zhejiang University
Author Profile
jian xu
Zhejiang University
Author Profile
xiuying chen
Zhejiang University

Corresponding Author:[email protected]

Author Profile

Abstract

Background: Concerns of COVID-19 vaccine safety from pregnant women still widespread. We used transcriptomic profile analysis to study changes of the maternal-fetal interface after vaccination and explore the possible protective effects from vaccination against miscarriage. Methods: We collected decidual tissuesafter uterine curettage from pregnant women in the first trimister with (n = 6) and without a COVID-19 vaccination (n = 6) and performed RNA-sequencing. Furthermore, we ananlyzed our transcriptome datas of samples and other datasets about maternal-fetal interface and miscarrige to analyze the potential link by bioinformatics tools. Results: We identified 879 different expressed genes from pregnant women who received vaccination and found that the COVID-19 vaccine could alter some hazardous RSA-related genes, such as CXCL11, FOS, FOSB, LY96, MMP10, and NCF2. Vaccination also changed some hazardous RSA-related signaling pathway.These molecules induced the transformation of M2 macrophages and promoted the balance of Th1/Th2 immune responses. Finally, these effects on the immune microenvironment of the maternal-fetal interface also showed corresponding positive changes. Conclusion: Many RSA-related signaling molecules were reversed after COVID-19 vaccination, indicating that the vaccine did not cause RSA, and these molecules ultimately may have protective effects on miscarriage by influencing the immune microenvironment at the maternal-fetal interface.